HEOR scientists in the pharma industry must balance methodologic rigor with commercial expectations and timelines.
John Graham, PharmD
Advertisement
Articles by John Graham, PharmD
HEOR requires executive leaders who have both scientific and managerial acumen.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
5
